Loading...
Header Logo
Keywords
Last Name
Institution

ROBERT P LEHMANN

TitleClinical Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Ophthalmology
DivisionOphthalmology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Reply. Ophthalmology. 2018 01; 125(1):e11-e12. PMID: 29268872.
      View in: PubMed
    2. Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Reply. Ophthalmology. 2018 01; 125(1):e4-e6. PMID: 29268874.
      View in: PubMed
    3. Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Reply. Ophthalmology. 2018 01; 125(1):e9-e10. PMID: 29268878.
      View in: PubMed
    4. Lehmann R, Modi S, Fisher B, Michna M, Snyder M. Bilateral implantation of +3.0 D multifocal toric intraocular lenses: results of a US Food and Drug Administration clinical trial. Clin Ophthalmol. 2017; 11:1321-1331. PMID: 28790805.
      View in: PubMed
    5. Singh RP, Staurenghi G, Pollack A, Adewale A, Walker TM, Sager D, Lehmann R. Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies. Clin Ophthalmol. 2017; 11:1021-1029. PMID: 28603408.
      View in: PubMed
    6. Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies. Ophthalmology. 2017 06; 124(6):776-785. PMID: 28268098.
      View in: PubMed
    7. Woodcock MG, Lehmann R, Cionni RJ, Breen M, Scott MC. Intraoperative aberrometry versus standard preoperative biometry and a toric IOL calculator for bilateral toric IOL implantation with a femtosecond laser: One-month results. J Cataract Refract Surg. 2016 06; 42(6):817-25. PMID: 27373387.
      View in: PubMed
    8. Whitman J, Dougherty PJ, Parkhurst GD, Olkowski J, Slade SG, Hovanesian J, Chu R, Dishler J, Tran DB, Lehmann R, Carter H, Steinert RF, Koch DD. Treatment of Presbyopia in Emmetropes Using a Shape-Changing Corneal Inlay: One-Year Clinical Outcomes. Ophthalmology. 2016 Mar; 123(3):466-75. PMID: 26804761.
      View in: PubMed
    9. Modi SS, Lehmann RP, Walters TR, Fong R, Christie WC, Roel L, Nethery D, Sager D, Tsorbatzoglou A, Philipson B, Traverso CE, Reiser H. Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study. J Cataract Refract Surg. 2014 Feb; 40(2):203-11. PMID: 24345529.
      View in: PubMed
    10. Packer M, Fry L, Lavery KT, Lehmann R, McDonald J, Nichamin L, Bearie B, Hayashida J, Altmann GE, Khodai O. Safety and effectiveness of a glistening-free single-piece hydrophobic acrylic intraocular lens (enVista). Clin Ophthalmol. 2013; 7:1905-12. PMID: 24109169; PMCID: PMC3792945.
    11. Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol. 2012; 6:1259-69. PMID: 22927737; PMCID: PMC3422154.
    12. Lehmann RP, Houtman DM. Visual performance in cataract patients with low levels of postoperative astigmatism: full correction versus spherical equivalent correction. Clin Ophthalmol. 2012; 6:333-8. PMID: 22399846; PMCID: PMC3295631.
    13. Maxwell WA, Cionni RJ, Lehmann RP, Modi SS. Functional outcomes after bilateral implantation of apodized diffractive aspheric acrylic intraocular lenses with a +3.0 or +4.0 diopter addition power Randomized multicenter clinical study. J Cataract Refract Surg. 2009 Dec; 35(12):2054-61. PMID: 19969208.
      View in: PubMed
    14. Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. 2007 Sep; 33(9):1539-45. PMID: 17720067.
      View in: PubMed
    15. Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg. 2007 Jan; 33(1):53-8. PMID: 17189793.
      View in: PubMed
    16. Lehmann R, Waycaster C, Hileman K. A comparison of patient-reported outcomes from an apodized diffractive intraocular lens and a conventional monofocal intraocular lens. Curr Med Res Opin. 2006 Dec; 22(12):2591-602. PMID: 17166341.
      View in: PubMed
    17. Marshall J, Cionni RJ, Davison J, Ernest P, Lehmann R, Maxwell WA, Solomon K. Clinical results of the blue-light filtering AcrySof Natural foldable acrylic intraocular lens. J Cataract Refract Surg. 2005 Dec; 31(12):2319-23. PMID: 16473224.
      View in: PubMed
    18. Wilhelmus KR, Font RL, Lehmann RP, Cernoch PL. Cytomegalovirus keratitis in acquired immunodeficiency syndrome. Arch Ophthalmol. 1996 Jul; 114(7):869-72. PMID: 8660174.
      View in: PubMed
    LEHMANN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description